Table III.

Adjusted regression analysis of the risks of death and reaching to the composite endpoint within 30 days after hospitalization

	Composite endpoint			Death
	OR	95% CI	P value	OR	95% CI	P value
Chronic respiratory diseases
Presence of chronic respiratory diseases∗	1.49	1.29, 1.71	<.001	0.84	0.68, 1.04	.106
Any other systemic comorbidity†	1.75	1.64, 1.86	<.001	1.88	1.70, 2.08	<.001
Female sex‡	1.30	1.23, 1.38	<.001	1.87	1.70, 2.05	<.001
Age§	1.03	1.02, 1.03	<.001	1.07	1.07, 1.08	<.001
COPD
Presence of COPD∗	1.71	1.44, 2.03	<.001	1.01	0.80, 1.27	.956
Any other systemic comorbidity†	1.75	1.64, 1.86	<.001	1.88	1.69, 2.08	<.001
Female sex‡	1.30	1.22, 1.38	<.001	1.85	1.68, 2.04	<.001
Age§	1.03	1.02, 1.03	<.001	1.07	1.07, 1.08	<.001
Asthma
Presence of asthma∗	1.45	1.05, 1.98	.022	0.84	0.48, 1.48	.544
Any other systemic comorbidity†	1.76	1.65, 1.87	<.001	1.88	1.69, 2.08	<.001
Female sex‡	1.32	1.24, 1.40	<.001	1.85	1.69, 2.04	<.001
Age§	1.03	1.02, 1.03	<.001	1.07	1.07, 1.08	<.001
Bronchiectasis
Presence of bronchiectasis∗	0.91	0.67, 0.23	.534	0.38	0.21, 0.70	.002
Any other systemic comorbidity†	1.76	1.65, 1.87	<.001	1.88	1.70, 2.08	<.001
Female sex‡	1.32	1.24, 1.40	<.001	1.86	1.69, 2.04	<.001
Age§	1.03	1.02, 1.03	<.001	1.07	1.07, 1.08	<.001

CI, Confidence interval; COPD, chronic obstructive pulmonary disease; OR, odds ratio.

^∗Adjusted with the presence of any other systemic comorbidities, female sex, and age.

^†Adjusted with the presence of any chronic respiratory disease/COPD/asthma/bronchiectasis, female sex, and age.

^‡Adjusted with any chronic respiratory disease/COPD/asthma/bronchiectasis, any other systemic comorbidities, and age.

^§Adjusted with any chronic respiratory disease/COPD/asthma/bronchiectasis, any other systemic comorbidities, and female sex.